Academic Medical Center

Amsterdam 1105AZ

0 studies enrolling now · 43 studies all time

What they study most

Adrenocortical Carcinoma, Aortic Valve Stenosis, Atherosclerosis, Atrial Fibrillation, Barrett's Esophagus, Barretts Esophagus, Cardiovascular Disease, Cardiovascular Diseases, Chronic Lymphocytic Leukemia, Coronary Artery Disease, Crohn's Disease, Cystic Fibrosis

Studies at this site

• Intra-operative Pancreatoscopy in Patients With IPMN — Running, not enrolling
• A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
• Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma — Completed
• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Completed
• Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease — Completed
• A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma — Completed
• Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo — Completed
• A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis — Completed
• Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia — Completed
• Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
• Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis — Completed
• A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis — Completed
• Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer — Completed
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome — Completed
• A Study To Monitor Long-Term Treatment With PF-00547659 — Completed
• Long-Term Safety Of PF-00547659 In Ulcerative Colitis — Completed
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis — Completed
• A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) — Completed
• The Lipid-Rich Plaque Study — Completed
• A Study of VX-445 Combination Therapy in CF Subjects Homozygous for F508del (F/F) — Completed
• Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) — Completed
• Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease — Completed
• Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients — Completed
• International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device — Stopped early
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol — Completed
• LINX Reflux Management System Clinical Study Protocol — Completed
• A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia — Completed
• Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP) — Completed
• A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE) — Completed
• The CHIPS Trial (Control of Hypertension In Pregnancy Study) — Completed
• Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management — Completed
• The Cooling And Surviving Septic Shock Study (CASS) — Stopped early
• Endoscopic Tri-Modal Imaging in Patients With Barrett's Esophagus — Completed
• MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction — Stopped early
• A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy — Completed
• A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3) — Completed
• Testing the Developmental Origins Hypothesis — Status unconfirmed